Latest News

• share
• favorite_border

With the growing awareness of ultraviolet (UV) exposure resulting in an increased risk of photoaging and skin cancers, consumers are using higher sun protection factor (SPF) sunscreens with frequent reapplication. New research, Evaluation of Reapplication and Controlled Heat Exposure on Oxybenzone Permeation from Commercial Sunscreen Using Excised Human Abdominal Skin, presented today at the 2018 American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 Meeting demonstrates that heat and reapplication influences different sunscreen products containing the same amount of a key ingredient, oxybenzone, potentially affecting safety and toxicity of the UV filters included in sunscreens.

• share
• favorite_border

There are over six million fractures per year in the U.S. with direct costs in the billions, not to mention lost productivity. The only drug currently available to accelerate the healing process must be applied directly onto the fracture surface during surgery, but not all breaks require such intervention. New research, Bone Fracture-Targeted Dasatinib Conjugate Potently Enhances Fracture Repair In Vivo, presented today at the 2018 American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 Meeting highlights a novel bone anabolic agent that, when injected, intravenously reduces femur fracture healing time by 60 percent without impacting the surrounding healthy tissue.

• share
• favorite_border

A widely used naloxone nasal spray (NNS) and naloxone injection (NIJ), otherwise known as Narcan® and Evzio®, which are administered to prevent opioid overdose deaths, were found to be chemically stable up for at least ten months and beyond one year of the expiration date, respectively.

• share
• favorite_border

AAPS Announces 2018 Distinguished Pharmaceutical Scientist Award

• share
• favorite_border

The American Association of Pharmaceutical Scientists (AAPS) is pleased to announce the elevation of six recipients to AAPS Fellow (FAAPS), one of the highest honors given to members of the association. Each year

• share
• favorite_border

Joseph W. Polli, Ph.D., FAAPS, GlaxoSmithKline has been elected to serve as president-elect of the American Association of Pharmaceutical Scientists (AAPS), a professional member-based organization of approximately 9,000 located in Arlington, VA.

• share
• favorite_border

According to Clarivate Analytics’ Journal Citation Reports, the 2017 impact factors for AAPS’ journals were all highly ranked in the category of Pharmacology and Pharmacy.

• share
• favorite_border

A new open-access white paper discusses the practical aspects of attribute selection and ranking, a critical first step in biosimilar drug development. These updated analytical standards were compiled by an international, multidisciplinary team involving FDA and pharmaceutical industry experts, and The American Association of Pharmaceutical Scientists (AAPS), which published the paper today in The AAPS Journal.

• share
• favorite_border

he American Association of Pharmaceutical Scientists (AAPS) is pleased to announce the availability of the open-access white paper entitled “Rational Selection, Criticality Assessment, and Tiering of Quality Attributes and Test Methods for Analytical Similarity Evaluation of Biosimilars.”

• share
• favorite_border

Dale Eric Wurster, Ph.D., FAAPS, has been elected to serve as president-elect of the American Association of Pharmaceutical Scientists (AAPS), a professional member-based organization of approximately 9,000 located in Arlington, VA. He will begin a three-year term on the AAPS Board of Directors (as president-elect, president, and immediate past president) in November of this year at the 2017 AAPS Annual Meeting and Exposition in San Diego. The meeting anticipates an attendance of over 6,500 pharmaceutical scientists from around the world.

• share
• favorite_border

The AAPS Journal, AAPS PharmSciTech and Pharmaceutical Research receive impactful measurement numbers in new report

• share
• favorite_border

The American Association of Pharmaceutical Scientists (AAPS), recognized ground-breaking research in the pharmaceutical sciences with awards presented at the 2017 National Biotechnology Conference.

• share
• favorite_border

Newest eCourse focuses on role of Transporters in Drug Discovery, Development, and Pharmacotherapy

• share
• favorite_border

The Zika virus is most commonly transmitted in humans as the result of a bite from an infected mosquito or from an infected human to another human. What is not well known is that the virus also can be transmitted via the environment if an individual is pricked with an infected needle or has an open cut and comes in contact with the live virus. While there are no known cases to date of the general public being infected with the Zika virus through the environment, there has been at least one documented case of laboratory acquired Zika virus infection.

• share
• favorite_border

Tuberculosis (TB) is responsible for more than 1.8 million deaths each year, according to the World Health Organization, yet there has been little significant improvement in therapies in the past 20 years. This chronic disease is systemic, meaning it affects not only the lungs but also other organs, such as the lymph nodes and spleen. But a promising new treatment may be on the horizon.

• share
• favorite_border

People with diabetes are one step closer to more easily checking their blood glucose levels with a non-invasive device for detecting and monitoring blood glucose levels, which is currently in development. The hand-held breathalyzer device detects acetone, which has been linked to high blood glucose levels in the breath. The research is being presented at the 2016 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world’s largest pharmaceutical sciences meeting. The meeting is taking place in Denver Nov. 13–17.

• share
• favorite_border

The American Association of Pharmaceutical Scientists (AAPS) has selected the award winning manuscripts from three research journals: The AAPS Journal, AAPS PharmSciTech, and Pharmaceutical Research, and. Each of these manuscript awards aim to recognize contributions to the pharmaceutical sciences as demonstrated by the respective authors.

• share
• favorite_border

The American Association of Pharmaceutical Scientists (AAPS) is pleased to announce the elevation of nine recipients to Fellow, one of the highest honors given to members of the association. Each year, AAPS elevates a few members to Fellow in recognition of their professional excellence in fields relevant to AAPS’s mission: to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health.

• share
• favorite_border

The American Association of Pharmaceutical Scientists is pleased to announce the 2016 Dale E. Wurster recipient, Stephen R. Byrn, Ph.D., of Purdue University. Byrn is recognized for his work in the field of Solid State Chemistry of Drugs. Supported by the Dale E. Wurster Endowment, this award is given to individuals who have made significant contributions to the pharmaceutical sciences in the specific field of pharmaceutics.

• share
• favorite_border

The 2016 AAPS Annual Meeting and Exposition will bring together more than 6,500 scientists, business leaders, government officials and students from around the world to share and learn the latest scientific advances and industry developments.